Synthesis and Quality Control of Viral Membrane Proteins
Viruses use the host cellular machinery to translate viral proteins. Similar to cellular proteins directed to the secretory pathway, viral (glyco)proteins are synthesized on polyribosomes and targeted to the endoplasmic reticulum (ER). For viruses that encode polyproteins, folding of the individual proteins of the precursor often is coordinated. Translocation and the start of folding coincide and are assisted by cellular folding factors present in the lumen of the ER. The protein concentration a newborn protein finds in this compartment is enormous (hundreds of mg/ml) and the action of molecular chaperones is essential to prevent aggregation. Viral envelope proteins also undergo the cellular quality control mechanisms, which ensure, with variable stringency, that only proteins with the correct structure will proceed through the secretory pathway. Proteins that are misfolded, or not yet folded, are retained in the ER until they reach the native conformation or until their retrotranslocation into the cytosol for degradation. Peculiar characteristic of viruses is their ability to interfere with the cellular machinery to ensure virus production and, moreover, to pass through the body unobserved by the host immune system. This section describes some mechanisms of genetic variation and viral immune evasion that involve the secretory pathway.
KeywordsMajor Histocompatibility Complex Class Cystic Fibrosis Transmembrane Conductance Regulator Unfold Protein Response Protein Disulfide Isomerase Disulfide Bond Formation
Unable to display preview. Download preview PDF.
- Blagoveshchenskaya AD, L Thomas, SF Feliciangeli, CH Hung and G Thomas (2002) HIV-1 Nef downregulates MHC-I by a PACS-1-and PI3K-regulated ARF6 endocytic pathway. Cell 111(6): 853–66Google Scholar
- Braakman, I., D. Hebert. Disulfide (-SS-) bond formation overview. In: Current Protocols in Protein Science, Chapter 14.1 (eds. J. Coligan, B. Dunn, H. Ploegh, D. Speicher, P. Wingfield; John Wiley and Sons, Inc, New York, 1996): 14.1.1–14.1.15Google Scholar
- Hegde NR, RA Tomazin, TW Wisner, C Dunn, JM Boname, DM Lewinsohn and DC Johnson (2002) Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation. J Virol 76(21): 10929–41CrossRefPubMedGoogle Scholar
- Kerkau T, I Bacik, JR Bennink, JW Yewdell, T Hunig, A Schimpl and U Schubert (1997) The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules. J Exp Med 185(7): 1295–305CrossRefPubMedGoogle Scholar
- Land A, D Zonneveld and I Braakman (2003) Folding of HIV-1 envelope glycoprotein involves extensive isomerization of disulfide bonds and conformation-dependent signal peptide cleavage. FASEB J in pressGoogle Scholar